FDA warning letter
Issue date
16 Oct 2023
Issuing office
Center for Drug Evaluation and Research | CDER
Posted date
16 Oct 2023
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Headquarters
Sites
Issue date
Issuing office
Posted date
Subject
Products & Services